Cue Biopharma Inc buy Jefferies Financial Group Inc.
Start price
13.03.24
/
50%
€1.97
Target price
13.03.25
€5.48
Performance (%)
-72.57%
Price
15.08.24
€0.54
Summary
This prediction is currently active. The BUY prediction by Jefferies_Financial_ for Cue Biopharma Inc is performing very badly with a performance of -72.57%. This prediction currently runs until 13.03.25. The prediction end date can be changed by Jefferies_Financial_ at any time. Jefferies_Financial_ has 50% into this predictionPerformance without dividends (%)
Name | 1w | 1m |
---|---|---|
Cue Biopharma Inc | -13.600% | -13.600% |
iShares Core DAX® | 2.821% | -1.953% |
iShares Nasdaq 100 | 5.285% | -5.092% |
iShares Nikkei 225® | 3.687% | -4.221% |
iShares S&P 500 | 3.577% | -2.240% |
Comments by Jefferies_Financial_ for this prediction
In the thread Cue Biopharma Inc diskutieren
Cue Biopharma, Inc. (NASDAQ: CUE) is now covered by analysts at Jefferies Financial Group Inc.. They set a "buy" rating and a $6.00 price target on the stock.
Ratings data for CUE provided by MarketBeat